- Home
- GRRR vs NOTV Comparison
GRRR vs NOTV Comparison
Compare GRRR & NOTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRRR
- NOTV
- Stock Information
- Founded
- GRRR 2001
- NOTV 1974
- Country
- GRRR United Kingdom
- NOTV United States
- Employees
- GRRR N/A
- NOTV N/A
- Industry
- GRRR Computer Software: Prepackaged Software
- NOTV Biotechnology: Pharmaceutical Preparations
- Sector
- GRRR Technology
- NOTV Health Care
- Exchange
- GRRR Nasdaq
- NOTV Nasdaq
- Market Cap
- GRRR 85.6M
- NOTV 101.2M
- IPO Year
- GRRR N/A
- NOTV 1997
- Fundamental
- Price
- GRRR $13.37
- NOTV $4.08
- Analyst Decision
- GRRR Buy
- NOTV Strong Buy
- Analyst Count
- GRRR 1
- NOTV 3
- Target Price
- GRRR $13.00
- NOTV $5.92
- AVG Volume (30 Days)
- GRRR 2.7M
- NOTV 1.5M
- Earning Date
- GRRR 01-03-2025
- NOTV 02-05-2025
- Dividend Yield
- GRRR N/A
- NOTV N/A
- EPS Growth
- GRRR N/A
- NOTV N/A
- EPS
- GRRR 2.28
- NOTV N/A
- Revenue
- GRRR $78,940,347.00
- NOTV $490,739,000.00
- Revenue This Year
- GRRR $12.29
- NOTV $7.14
- Revenue Next Year
- GRRR $21.40
- NOTV $5.73
- P/E Ratio
- GRRR $5.87
- NOTV N/A
- Revenue Growth
- GRRR 424.97
- NOTV N/A
- 52 Week Low
- GRRR $2.09
- NOTV $1.23
- 52 Week High
- GRRR $14.37
- NOTV $11.42
- Technical
- Relative Strength Index (RSI)
- GRRR 87.34
- NOTV 51.14
- Support Level
- GRRR $5.75
- NOTV $3.55
- Resistance Level
- GRRR $8.24
- NOTV $6.48
- Average True Range (ATR)
- GRRR 1.32
- NOTV 0.80
- MACD
- GRRR 0.60
- NOTV -0.12
- Stochastic Oscillator
- GRRR 88.40
- NOTV 21.31
About GRRR Gorilla Technology Group Inc. Ordinary shares
Gorilla Technology Group Inc is primarily engaged in providing information, software, and data processing services. It is a provider of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology (OT) security solutions and services. Its reportable segments are video IoT and security convergence and Other segments.
About NOTV Inotiv Inc.
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.